← AbbVie
Episodes featuring AbbVie
50 episodes, newest first.
- Oct 13, 2026
China’s chip push tests AI stocks and market leadersCNBC's "Fast Money"Oct 13, 2026 - Oct 9, 2026
Markets advance as power-trend confirmation remains incompleteStock Market Today With IBDOct 9, 2026 - Oct 9, 2026
AI rally faces concentration, spending and valuation testsHalftime ReportOct 9, 2026 - Oct 7, 2026
Mega-cap strength masks widening market weaknessStock Market Today With IBDOct 7, 2026 - Oct 7, 2026
AI buildout collides with higher rates and scarce capitalClosing BellOct 7, 2026 - Oct 6, 2026
Genmab trial lifts shares as BPCE expands into SabadellStock MoversOct 6, 2026 - Oct 5, 2026
Dollar strength reshapes bets across tech, banks and global marketsCNBC's "Fast Money"Oct 5, 2026 - Oct 5, 2026
Freight consolidation meets the financing test for AI’s next buildoutBloomberg IntelligenceOct 5, 2026 - Sep 28, 2026
Bimagrumab exposes the hard economics of drug developmentThe Peter Attia DriveSep 28, 2026 - Aug 26, 2026
Solvonis bets £1.3 million on three clinical programmesThe Sunday RoastAug 26, 2026 - Aug 17, 2026
Alec Litowitz argues adaptability beats certainty in investingHow I Invest with David WeisburdAug 17, 2026 - Jul 15, 2026
Cramer demands proof for AI’s next spending surgeMad Money w/ Jim CramerJul 15, 2026 - Jun 30, 2026
AI fears sink Concentrix while lawmakers target Merck and AbbVie trialsStock MoversJun 30, 2026 - Jun 22, 2026
Super Micro surges on upgrade while Alphabet slides amid AI talent departuresStock MoversJun 22, 2026 - Jun 22, 2026
AbbVie targets Apogee in eleven billion dollar deal as Regenxbio advancesStock MoversJun 22, 2026 - Jun 22, 2026
Acquisition rumors and major AI alliances spark pre-market stock surgesStock MoversJun 22, 2026 - Apr 7, 2026
Cramer weighs market fear against durable stock storiesMad Money w/ Jim CramerApr 7, 2026 - Apr 5, 2026
Soprano Lise Davidsen navigates opera and motherhood after twin birthThe DailyApr 5, 2026 - Mar 19, 2026
Cramer tests whether the selloff rewards disciplined buyersMad Money w/ Jim CramerMar 19, 2026 - Feb 28, 2026
AI spending forces investors to rethink scale and riskMad Money w/ Jim CramerFeb 28, 2026 - Feb 26, 2026
AI infrastructure holds up as Wall Street questions old defensesMad Money w/ Jim CramerFeb 26, 2026 - Jan 17, 2026
Cramer links market volatility to business quality and chip demandMad Money w/ Jim CramerJan 17, 2026 - Jan 15, 2026
Cramer turns cautious as banks and growth stocks lose momentumMad Money w/ Jim CramerJan 15, 2026 - Jan 9, 2026
Cramer urges caution as speculation collides with market momentumMad Money w/ Jim CramerJan 9, 2026